Action 002864 SHAANXI PANLONG PHARMACEUTICAL GROUP LIMITED BY SHARE LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd

Actions

002864

CNE1000032C9

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
25,88 CNY -0,27% Graphique intraday de Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd -2,78% -32,76%
28/05 Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. annonce un dividende final sur les actions A pour l'annee 2023, payable le 3 juin 2024 CI
22/05 Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd approuve le dividende en espèces pour l'année 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Announces Final Dividend on A Shares for the Year 2023, Payable on 03 June 2024
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Approves Cash Dividend for the Year 2023
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd Proposes Final Cash Dividend for the Year 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's Equity Buyback Plan announced on March 14, 2024.
Panlong Pharmaceutical Plans 20 Million Yuan Share Buyback
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announces an Equity Buyback for CNY 20 million worth of its shares.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd authorizes a Buyback Plan.
Panlong Pharmaceutical Gets Sanitary License
Panlong Pharmaceutical Gets Certificate for Shaanxi Good Trademark
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd announced that it has received CNY 301.999975 million in funding
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Panlong Pharma Completes Registration of New Medical Clinic
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Approves Cash Dividend for 2022, Payable on May 31, 2023
Chinese Shares Retreat; Panlong Pharma Falls 7% on 302 Million Yuan Share Sale
Shaanxi Panlong Pharma Selling 302 Million Yuan Shares to Fund New Projects
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd. Proposes Final Cash Dividend for 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002864
  4. Actualités Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
  5. Autres langues